Angiotensin-converting enzyme gene polymorphism and plasminogen activator inhibitor 1 levels in subjects with cerebral infarction

Journal of Thrombosis and Thrombolysis

Volumn 5, Issue 3, 1998, Pages 263-267

  Seino, Yoshitane ^a   Ikeda, Uichi ^a   Maeda, Yoshikazu ^a   Haga, Yasushi ^b   Yashima, Harumitsu ^c   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Inawashiro Hospital   (Japan)

^c Miyashita Hospital   (Japan)

Author keywords

Angiotensin; Cerebral infarction; Plasminogen; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031776690     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008804211738     Document Type: Article

References (37)

1. Rigat B, Hubert C, Alhenc GF, Cambien F, Corvol P Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86: 1343-1346.
2. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
3. Tiret L, Kee F, Poirier O, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341: 991-992.
4. Badenhop RF, Wang XL, Wilcken DE. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995;91:1655-1658.
5. Raynolds MV, Bristow MR, Bush EW, et al. Angiotensinconverting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993;342: 1073-1075.
6. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: A link to cardiovascular hypertrophy? J Hypertens 1991;9:3-15.
7. Castellano M, Muiesan ML, Rizzoni D, et al. Angiotensinconverting enzyme I/D polymorphism and arterial wall thickness in a general population; The Vobarno Study. Circulation 1995;91:2721-2724.
8. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
9. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90: 2622-2628.
10. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-1086.
11. Sharma P, Carter ND, Barley J, Brown MM. Molecular approach to assessing the genetic risk of cerebral infarction: Deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens 1994;8:645-648.
12. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, Brown MM. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacular cerebral infarction but not carotid atheroma. Cereb Infarc 1995;26: 1329-1333.
13. Maeda Y, Ikeda U, Ebata H, et al. Angiotensin-converting enzyme gene polymorphism in hypertensive individuals with parental history of stroke. Stroke 1996;27:1521-1523.
14. Margaglione M, Celentano E, Grandone E, et al. Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996;16:304-309.
15. Mannucci PM, Mari D, Merati G, et al. Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins: A study in centenarians. Arterioscler Thromb Vasc Biol 1997;17:755-759.
16. Hamsten A, Wiman B, deFaire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985;313:1556-1563.
17. Hamsten A, Walldins G, Szamosi A, et al. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;2:3-9.
18. Maragaglione M, DiMinno G, Grandone E, et al. Plasma lipoprotein(a) levels in subjects attending a metabolic ward: Discrimination between individuals with and without a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996;16:120-128.
19. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley DB, Loskutoff DJ. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992;89:6998-7002.
20. Ridker PM, Gaboury CL, Conlin PR, Seeley EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Circulation 1993;87:1969-1973.
21. Yusuf S, Peine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-1178.
22. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-677.
23. Special report from the National Institue of Neurological Disorders and Stroke. Classification of cerebrovascular disease III. Stroke 1990;21:637-676.
24. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;62:161-186.
25. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433-1433.
26. Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996;93: 1630-1633.
27. Ueda S, Weir CJ, Inglis GC, Murray GD, Muir KW, Lees KR. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and cerebral infarction. J Hypertens 1995;13:1597-1601.
28. SHEP Cooperative Research Group. Prevention of cerebral infarction by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
29. Charles TS Jr., Ibrahim FB, Saleem A, et al. Enalapril prevents cerebral infarction and kidney dysfunction in saltloaded cerebral infarction-prone spontaneously hypertensive rats. Hypertension 1989;13:115-121.
30. Danser AHJ, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Riegger GA. ACE in the human heart: Effect of the deletion/insertion polymorphism (abstr). Circulation 1995;92:I-29.
31. Costerousse O, Allegrini J, Lopez M, Alhenc GF. Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.
32. Hamsten A, de Faire U, Walldium G, et al. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;2:3-9.
33. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 1995;95:995-1001.
34. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995;95:1353-1362.
35. Wright RA, Flapan AD, Alberti KGMM, Ludlam CA, Fox KAA. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. J Am Coll Cardiol 1994;24:67-73.
36. Panahloo A, Andres C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE, Yudkin JS. The insertion allele of the ACE gene I/D polymorphism: A candidate gene for insulin resistance. Circulation 1995;92:3390-3393.
37. Higashimori K, Zhao Y, Higaki J, et al. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993;191:399-404.